Bayer reported its Q2 2025 earnings with sales reaching €10.74 billion and an adjusted EBITDA of €2.11 billion, surpassing estimates with a margin of 19.6% against the expected 17.2%. The company posted a core EPS of €1.23. Despite these results, Bayer's stock declined following a 44% drop in profits, although the company raised its annual forecasts driven by pharmaceutical growth and lower tax burdens. Bayer has reduced its workforce by 12,000 employees as part of ongoing restructuring efforts, with the CEO indicating no specific target for further job cuts but anticipating additional reductions over the next 18 months. Commerzbank also released its Q2 2025 results, reporting revenue of €3.02 billion, operating profit of €1.17 billion, and net income of €462 million, all exceeding analyst expectations. The bank's net interest income was slightly below estimates at €2.06 billion, and its CET1 ratio stood at 14.6%. Commerzbank announced a share buyback program of up to €1 billion and raised its profit guidance for 2025. Allianz posted an operating profit of €4.41 billion for Q2 2025, beating estimates, with revenue at €44.5 billion. The insurer completed a €1 billion share buyback in the first half of 2025 and maintained its full-year operating profit outlook between €15 billion and €17 billion. Deutsche Telekom reported Q2 revenue of €28.67 billion and adjusted EBITDA of €11 billion, both slightly above expectations. The company raised its full-year adjusted EBITDA outlook to above €45 billion and free cash flow post-lease to above €20 billion, citing strong sales in the US and Europe. Henkel's Q2 2025 revenue was €5.16 billion, slightly below estimates, but its H1 EBIT of €1.61 billion and adjusted EBIT margin of 15.5% exceeded forecasts. The company confirmed its full-year adjusted EBIT margin guidance between 14.5% and 15.5% and organic sales growth of 1% to 2%.